A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family
- PMID: 29947763
- DOI: 10.1093/europace/euy127
A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family
Abstract
Aims: Characterization of the cardiac phenotype associated with the novel LMNA nonsense mutation c.544C>T, p.Q182*, which we have identified in a large five-generation family.
Methods and results: A family tree was constructed. Clinical data [arrhythmia, syncope, sudden cardiac death (SCD), New York Heart Association (NYHA) class] were collected from living and deceased family members. DNA of 23 living family members was analysed for mutations in LMNA. Additionally, dilated cardiomyopathy multi-gene-panel testing and whole exome sequencing were performed in some family members to identify potential phenotype-modifiers. In this five-generation family (n = 65), 17 SCDs occurred at 49.3 ± 10.0 years. Furthermore, we identified eight additional mutation-carriers, seven symptomatic (44 ± 13 years), and one asymptomatic (44 years). First signs of disease [sinus bradycardia with atrioventricular (AV)-block I°] occurred at 36.5 ± 8.1 years. Paroxysmal atrial fibrillation (AF) (onset at 41.8 ± 5.7 years) rapidly progressed to permanent AF (46.2 ± 9.8 years). Subsequently, AV-conduction worsened, syncope, pacemaker-dependence, and non-sustained ventricular tachycardia (43.3 ± 8.2 years) followed. Ventricular arrhythmia caused SCD in patients without implantable cardioverter-defibrillator (ICD). Patients protected by ICD developed rapidly progressive heart failure (45.2 ± 10.6 years). A different phenotype was seen in a sub-family in three patients with early onset of rapidly decompensating heart failure and only minor prior arrhythmia-related symptoms. One patient received high-urgency heart transplantation (HTX) at 32 years, while two died prior to HTX. One of them developed lethal peripartum-associated heart failure. Possible disease-modifiers were identified in this 'heart failure sub-family'.
Conclusion: The novel LMNA nonsense mutation c.544C>T causes a severe arrhythmogenic phenotype manifesting with high incidence of SCD in most patients; and in one sub-family, a distinct phenotype with fast progressing heart failure, indicating the need for early consideration of ICD-implantation and listing for heart-transplantation.
Similar articles
-
Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.BMC Cardiovasc Disord. 2019 Dec 17;19(1):298. doi: 10.1186/s12872-019-01282-6. BMC Cardiovasc Disord. 2019. PMID: 31847799 Free PMC article.
-
Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.Heart Rhythm. 2013 Oct;10(10):1492-8. doi: 10.1016/j.hrthm.2013.06.020. Epub 2013 Jun 26. Heart Rhythm. 2013. PMID: 23811080
-
Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.PLoS One. 2015 Apr 2;10(4):e0121723. doi: 10.1371/journal.pone.0121723. eCollection 2015. PLoS One. 2015. PMID: 25837155 Free PMC article.
-
Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals.Clin Res Cardiol. 2017 Feb;106(2):127-139. doi: 10.1007/s00392-016-1033-6. Epub 2016 Aug 30. Clin Res Cardiol. 2017. PMID: 27576561 Review.
-
The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.Europace. 2013 Dec;15(12):1693-701. doi: 10.1093/europace/eut228. Epub 2013 Aug 14. Europace. 2013. PMID: 23946316 Review.
Cited by
-
What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow.Int J Mol Sci. 2024 Sep 30;25(19):10559. doi: 10.3390/ijms251910559. Int J Mol Sci. 2024. PMID: 39408885 Free PMC article. Review.
-
Cytoskeletal Protein Variants Driving Atrial Fibrillation: Potential Mechanisms of Action.Cells. 2022 Jan 25;11(3):416. doi: 10.3390/cells11030416. Cells. 2022. PMID: 35159226 Free PMC article. Review.
-
Updates on the Genetic Paradigm in Heart Failure.Curr Treat Options Cardiovasc Med. 2019 Jun 28;21(8):37. doi: 10.1007/s11936-019-0742-3. Curr Treat Options Cardiovasc Med. 2019. PMID: 31250202 Review.
-
Reevaluating the Mutation Classification in Genetic Studies of Bradycardia Using ACMG/AMP Variant Classification Framework.Int J Genomics. 2020 Feb 25;2020:2415850. doi: 10.1155/2020/2415850. eCollection 2020. Int J Genomics. 2020. PMID: 32211440 Free PMC article.
-
Management of ventricular tachycardias: insights on centre settings, procedural workflow, endpoints, and implementation of guidelines-results from an EHRA survey.Europace. 2024 Feb 1;26(2):euae030. doi: 10.1093/europace/euae030. Europace. 2024. PMID: 38363995 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous